Constipation and bloating
Pro Research Analysisby 
Searched over 200M research papers
Prevalence and Relationship of Constipation and Bloating
Constipation and bloating are common gastrointestinal symptoms that often occur together. Studies show that about a quarter of patients report significant bloating, and this symptom is especially common in those with constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC) Ryu2016Said2022. Bloating is more likely to be associated with constipation than with diarrhea, and patients who report bloating as a main symptom are also more likely to experience constipation, incomplete evacuation, and abdominal pain Ryu2016Said2022. In patients with chronic kidney disease, both constipation and bloating are also highly prevalent, further impacting quality of life .
Symptom Patterns and Impact
Bloating and constipation tend to occur in episodes rather than randomly. For example, constipation episodes typically last about 4.5 days, while bloating episodes last around 3.5 days. These symptoms often overlap, but not always—bloating can occur independently of constipation or pain . The severity of bloating is closely linked to the severity of constipation and abdominal pain, and both symptoms can significantly reduce quality of life Ryu2016Palsson2014Said2022.
Treatment Options for Constipation and Bloating
Secretagogues and Prokinetics
Several medications have been shown to improve both constipation and bloating:
- Linaclotide: In patients with CIC and moderate-to-severe bloating, linaclotide significantly improved both bowel movements and bloating compared to placebo .
- Plecanatide: This medication also led to significant improvements in constipation and reductions in bloating in both CIC and IBS-C patients .
- Lubiprostone: Lubiprostone improved constipation, stool consistency, and bloating, with benefits seen as early as one week and lasting up to three months .
- Prucalopride: In patients with moderate to very severe bloating and CIC, prucalopride led to greater improvements in bloating than placebo, regardless of the main complaint at baseline .
Herbal and Dietary Interventions
A combination extract of Quebracho, Conker Tree, and M. balsamea Willd has shown promise in improving constipation, bloating, and abdominal discomfort in IBS-C patients who did not respond to traditional treatments, with most patients reporting symptom relief and improved quality of life . Dietary changes, such as reducing foods that cause fermentation, and the use of prebiotics or probiotics, can also help reduce bloating by decreasing gas production .
Other Management Strategies
Non-pharmacological approaches, including dietary modifications and biofeedback therapy, may be beneficial, especially for patients with objective abdominal distension or outlet obstructed defecation . Pharmacological treatments may also target intestinal transit, gas tolerance, and the gut microbiota .
Conclusion
Constipation and bloating frequently co-occur, especially in functional gastrointestinal disorders like IBS-C and CIC. These symptoms are episodic, often overlap, and can significantly impact daily life. Multiple treatment options—including secretagogues, prokinetics, herbal extracts, and dietary interventions—have demonstrated effectiveness in improving both constipation and bloating. Addressing constipation is often a key step in managing bloating, and a combination of pharmacological and non-pharmacological strategies may provide the best outcomes for patients.
Sources and full results
Most relevant research papers on this topic